CN1124502A - 哺乳动物细胞系和获得糖蛋白的方法 - Google Patents

哺乳动物细胞系和获得糖蛋白的方法 Download PDF

Info

Publication number
CN1124502A
CN1124502A CN94192251A CN94192251A CN1124502A CN 1124502 A CN1124502 A CN 1124502A CN 94192251 A CN94192251 A CN 94192251A CN 94192251 A CN94192251 A CN 94192251A CN 1124502 A CN1124502 A CN 1124502A
Authority
CN
China
Prior art keywords
cell
glycoprotein
substratum
hamster
protein
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN94192251A
Other languages
English (en)
Chinese (zh)
Inventor
H·沃尔夫
K·查尔芬伯格
R·瓦格纳
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Helmholtz Zentrum fuer Infektionsforschung HZI GmbH
Original Assignee
Helmholtz Zentrum fuer Infektionsforschung HZI GmbH
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Helmholtz Zentrum fuer Infektionsforschung HZI GmbH filed Critical Helmholtz Zentrum fuer Infektionsforschung HZI GmbH
Publication of CN1124502A publication Critical patent/CN1124502A/zh
Pending legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/16011—Herpesviridae
    • C12N2710/16211—Lymphocryptovirus, e.g. human herpesvirus 4, Epstein-Barr Virus
    • C12N2710/16222—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Virology (AREA)
  • Medicinal Chemistry (AREA)
  • Biophysics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Genetics & Genomics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
CN94192251A 1993-04-26 1994-04-26 哺乳动物细胞系和获得糖蛋白的方法 Pending CN1124502A (zh)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE4313620A DE4313620A1 (de) 1993-04-26 1993-04-26 Hamsterzellinien und Verfahren zur Glykoproteingewinnung
DEP4313620.6 1993-04-26

Publications (1)

Publication Number Publication Date
CN1124502A true CN1124502A (zh) 1996-06-12

Family

ID=6486397

Family Applications (1)

Application Number Title Priority Date Filing Date
CN94192251A Pending CN1124502A (zh) 1993-04-26 1994-04-26 哺乳动物细胞系和获得糖蛋白的方法

Country Status (9)

Country Link
EP (1) EP0695357A1 (ja)
JP (1) JPH08509369A (ja)
KR (1) KR100255228B1 (ja)
CN (1) CN1124502A (ja)
AU (1) AU6722094A (ja)
CA (1) CA2161517A1 (ja)
DE (1) DE4313620A1 (ja)
NZ (1) NZ266146A (ja)
WO (1) WO1994025599A1 (ja)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101048511B (zh) * 2004-08-27 2012-07-18 惠氏研究爱尔兰有限公司 多肽的生产

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6475725B1 (en) 1997-06-20 2002-11-05 Baxter Aktiengesellschaft Recombinant cell clones having increased stability and methods of making and using the same
AT409379B (de) 1999-06-02 2002-07-25 Baxter Ag Medium zur protein- und serumfreien kultivierung von zellen
JP2003506077A (ja) * 1999-08-05 2003-02-18 バクスター アクチェンゲゼルシャフト 組換え安定細胞クローン、その産生およびその使用
EP2287288B1 (en) 2002-07-09 2012-11-07 Baxter International Inc. Animal protein free media for cultivation of cells
US20060094104A1 (en) 2004-10-29 2006-05-04 Leopold Grillberger Animal protein-free media for cultivation of cells
EP1974014B1 (en) 2006-01-04 2017-04-19 Baxalta Incorporated Oligopeptide-free cell culture media
JP5995397B2 (ja) * 2009-03-09 2016-09-21 東洋製罐グループホールディングス株式会社 細胞培養方法、及び細胞培養装置
JP2011004754A (ja) * 2010-08-05 2011-01-13 Baxter Ag 組換え安定細胞クローン、その産生およびその使用
WO2014062535A1 (en) 2012-10-15 2014-04-24 Bristol-Myers Squibb Company Mammalian cell culture processes for protein production
JP6097725B2 (ja) * 2014-07-09 2017-03-15 バクスアルタ・イノベイションズ・ゲゼルシャフト・ミット・ベシュレンクテル・ハフツングＢａｘａｌｔａ Ｉｎｎｏｖａｔｉｏｎｓ ＧｍｂＨ 組換え安定細胞クローン、その産生およびその使用
JP6245299B2 (ja) * 2016-04-27 2017-12-13 バクスアルタ ゲーエムベーハー 組換え安定細胞クローン、その産生およびその使用

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NO162160C (no) * 1987-01-09 1989-11-15 Medi Cult As Serumfritt vekstmedium, samt anvendelse derav.
EP0312164A1 (en) * 1987-10-16 1989-04-19 Merck & Co. Inc. Purification of recombinant epstein-barr virus antigens from vero cells, yeast cells or L cells
GB9022545D0 (en) * 1990-10-17 1990-11-28 Wellcome Found Culture medium
JPH04228066A (ja) * 1990-10-23 1992-08-18 Rikagaku Kenkyusho 外来遺伝子発現用培養細胞

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101048511B (zh) * 2004-08-27 2012-07-18 惠氏研究爱尔兰有限公司 多肽的生产

Also Published As

Publication number Publication date
AU6722094A (en) 1994-11-21
CA2161517A1 (en) 1994-11-10
KR100255228B1 (ko) 2000-05-01
JPH08509369A (ja) 1996-10-08
DE4313620A1 (de) 1994-10-27
WO1994025599A1 (de) 1994-11-10
NZ266146A (en) 1997-11-24
EP0695357A1 (de) 1996-02-07

Similar Documents

Publication Publication Date Title
CN102575233B (zh) 从高细胞密度培养物纯化腺病毒的方法
CN1318577C (zh) 用于无蛋白无血清培养细胞的培养基
CN1124502A (zh) 哺乳动物细胞系和获得糖蛋白的方法
JP3313117B2 (ja) ウイルス粒子の効率の高い生産および単離
NO874357L (no) Rensing av pichia-produserte lipofile proteiner.
CN102791852A (zh) 纯化腺病毒颗粒的方法
CN112695053B (zh) 一种重组猫干扰素的制备方法
ES2341352T3 (es) Procedimiento para la preparacion de material virico.
RU2054044C1 (ru) Способ получения рекомбинантного человеческого свободного от метионина на n-конце гамма-интерферона
US5466781A (en) Process for purifying bacterially produced M-CSF
CN104372027A (zh) 慢病毒表达载体pLOX-CMV-E/P及其构建与应用
US8956812B2 (en) Process for the preparation and purification of recombinant proteins
FI96864B (fi) Ei-terapeuttisesti käytettävä HIV:n glykoproteiini GP 160 ja menetelmä sen valmistamiseksi
AU1369801A (en) Mammal cell lines and method of obtaining glycoproteins
CN117304344B (zh) 一种融合蛋白、表达该融合蛋白的重组菌株及其应用
CN115011566B (zh) 一种人用狂犬病疫苗中残留dna的去除方法
CN117050163B (zh) 一种分泌表达重组iii型胶原蛋白的毕赤酵母工程菌及其应用
Rafajko Routine establishment of serial lines of hamster embryo cells transformed by adenovirus type 12
CN1452658A (zh) 由遗传工程酵母生产人干扰素α的方法
EP0255383B1 (en) Improved mutant vaccinia virus and process for production thereof
CN105274123A (zh) 重组ulp1激酶的编码序列、编码蛋白、含有该编码序列的质粒、及重组ulp1激酶的制备方法
Hesse et al. Application of Protein-Free Cell Culture Media for the Manufacturing of Biopharmaceuticals
CN117844643A (zh) 一种基于转基因小球藻制备的重组流感疫苗的制备方法
CN116574753A (zh) 纯化制备抗新型冠状病毒感染的疫苗原液的方法
CN102406928A (zh) 一种人二倍体细胞脊髓灰质炎灭活疫苗的生产方法

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C02 Deemed withdrawal of patent application after publication (patent law 2001)
WD01 Invention patent application deemed withdrawn after publication